LEADER 02832oam 2200529 a 450 001 9910696625903321 005 20080617083646.0 035 $a(CKB)5470000002380605 035 $a(OCoLC)228635853 035 $a(EXLCZ)995470000002380605 100 $a20080523d2008 ua 0 101 0 $aeng 135 $aurmn||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aHigh-containment biosafety laboratories$b[electronic resource] $eDHS lacks evidence to conclude that foot-and-mouth disease research can be done safely on the U.S. mainland : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives /$fstatement of Nancy Kingsbury, United States Government Accountability Office 210 1$a[Washington, D.C.] :$cU.S. Govt. Accountability Office,$d[2008] 215 $a29 pages $cdigital, PDF file 225 1 $aTestimony ;$vGAO-08-821 T 300 $aTitle from title screen (viewed on May 23, 2008). 300 $a"For release on delivery ... May 22, 2008." 300 $aPaper version available from: U.S. Govt. Accountability Office, 441 G St., NW, Rm. LM, Washington, D.C. 20548. 320 $aIncludes bibliographical references. 330 $aDHS is proposing to move foot-and mouth disease (FMD) research from its current location at the Plum Island Animal Disease Center--located on a federally owned island off the northern tip of Long Island, New York--and potentially onto the United States mainland. In preparing this testimony, GAO interviewed officials from DHS and USDA, talked with experts in FMD and high-containment laboratories worldwide, and reviewed studies on FMD, high-containment laboratories, and the economic consequences of FMD outbreaks. 517 $aHigh-containment biosafety laboratories 606 $aMicrobiological laboratories$zUnited States 606 $aMedical laboratories$zUnited States 606 $aHealth risk assessment$zUnited States 606 $aEnvironmental risk assessment$zUnited States 606 $aFoot-and-mouth disease$xResearch 607 $aPlum Island (N.Y.)$xResearch 615 0$aMicrobiological laboratories 615 0$aMedical laboratories 615 0$aHealth risk assessment 615 0$aEnvironmental risk assessment 615 0$aFoot-and-mouth disease$xResearch. 700 $aKingsbury$b Nancy R$01380798 712 02$aUnited States.$bCongress.$bHouse.$bCommittee on Energy and Commerce.$bSubcommittee on Oversight and Investigations. 712 02$aUnited States.$bGovernment Accountability Office. 801 0$bEJB 801 1$bEJB 801 2$bGPO 906 $aBOOK 912 $a9910696625903321 996 $aHigh-containment biosafety laboratories$93434978 997 $aUNINA